Steminent Biotherapeutics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	499.18	205.4	451.86	153.43	230.56
Short-Term Investments	-	11.6	-	-	-
Cash & Short-Term Investments	499.18	217	451.86	153.43	230.56
Cash Growth	130.03%	-51.98%	194.50%	-33.45%	464.90%
Other Receivables	0.73	0.94	0.84	0.33	0.78
Receivables	0.73	0.94	0.84	0.33	0.78
Inventory	15.06	12	7.67	3.48	10.4
Prepaid Expenses	2.89	5.82	-	-	1.14
Other Current Assets	-	-	6.09	3.91	-
Total Current Assets	517.86	235.76	466.46	161.15	242.88
Property, Plant & Equipment	149.35	168.18	83.16	58.87	22.8
Other Intangible Assets	1.78	2.39	0.51	0.32	0.16
Other Long-Term Assets	29.51	30.34	43.74	15.31	13.66
Total Assets	698.49	436.66	593.88	235.65	279.5
Accounts Payable	2.85	2.54	2.15	1.93	0.65
Accrued Expenses	11.58	11.41	13.81	10.11	10.01
Current Portion of Leases	14.2	13.68	13.15	7.17	7.9
Current Unearned Revenue	-	-	-	0.46	1.09
Other Current Liabilities	9.52	4.09	9.55	4.46	2.85
Total Current Liabilities	38.15	31.73	38.66	24.12	22.5
Long-Term Debt	21.67	-	-	-	-
Long-Term Leases	37.5	50.09	62.23	48	11.27
Long-Term Deferred Tax Liabilities	0.03	0.15	-	-	-
Other Long-Term Liabilities	-	-	-	-	1.46
Total Liabilities	97.34	81.97	100.89	72.11	35.23
Common Stock	666.34	560.45	557.95	444.94	444.94
Additional Paid-In Capital	710.51	581.43	580.17	239.16	239.16
Retained Earnings	-988.31	-814.27	-655.53	-526.3	-440.82
Comprehensive Income & Other	212.61	27.09	10.39	5.74	0.99
Shareholders' Equity	601.15	354.7	492.99	163.54	244.27
Total Liabilities & Equity	698.49	436.66	593.88	235.65	279.5
Total Debt	73.36	63.78	75.38	55.16	19.17
Net Cash (Debt)	425.81	153.23	376.48	98.27	211.39
Net Cash Growth	177.90%	-59.30%	283.12%	-53.51%	-
Net Cash Per Share	7.22	2.74	7.77	2.21	6.00
Filing Date Shares Outstanding	66.63	56.05	55.8	44.49	44.49
Total Common Shares Outstanding	66.63	56.05	55.8	44.49	44.49
Working Capital	479.71	204.03	427.8	137.03	220.38
Book Value Per Share	9.02	6.33	8.84	3.68	5.49
Tangible Book Value	599.37	352.31	492.47	163.22	244.11
Tangible Book Value Per Share	9.00	6.29	8.83	3.67	5.49
Machinery	109.69	99.07	42.81	34.07	32.36
Leasehold Improvements	79.08	79.08	41.5	41.05	40.82

Source: S&P Global Market Intelligence. Standard template. Financial Sources.